#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2308	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2686	247.3	0	.	n	.	0	C451T	SNP	451	451	C	816	816	T	365	T,C	149,153	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2308	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2686	247.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1549	1549	C	343	C	295	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2308	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2686	247.3	0	HET	.	.	.	C207T,A	.	207	207	C	572	572	C	324	C,T,A	139,118,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2308	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2686	247.3	0	HET	.	.	.	C1450T	.	1450	1450	C	1815	1815	C	332	C,T	154,142	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3844	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3998	288.4	0	.	n	.	0	T695C	SNP	695	695	T	1268	1268	C	269	C	223	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3844	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3998	288.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2544	2544	C	344	C,T	289,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3844	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3998	288.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3170	3170	T	324	T	273	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3844	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3998	288.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2618	2618	A	340	A,G,C	293,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	420	folP	855	855	100.0	folP.l15.c4.ctg.1	2076	60.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1302	1304	AGC	90;90;90	A;G;C	77;78;78	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	932	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3848	72.6	1	SNP	p	S91F	1	.	.	271	273	TTC	862	864	TTC	94;95;95	T;T,C;C	81;81,1;81	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	932	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3848	72.6	1	SNP	p	D95G	1	.	.	283	285	GGC	874	876	GGC	101;101;102	G;G,A;C,T	86;88,1;87,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	932	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3848	72.6	1	SNP	p	G95N	0	.	.	283	285	GGC	874	876	GGC	101;101;102	G;G,A;C,T	86;88,1;87,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	340	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1856	55.0	1	SNP	p	G45D	0	.	.	133	135	GGC	745	747	GGC	87;87;87	G;G;C	74;73;76	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	182	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1325	41.0	0	.	n	.	0	A197.	DEL	197	197	A	844	844	A	71	A	65	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	78.9	1	SNP	p	D86N	0	.	.	256	258	GAC	751	753	GAC	95;95;95	G;A;C	79;79;80	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	78.9	1	SNP	p	R87W	0	.	.	259	261	CGT	754	756	CGT	95;96;96	C,A;G;T	81,1;81;81	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	78.9	1	SNP	p	R87I	0	.	.	259	261	CGT	754	756	CGT	95;96;96	C,A;G;T	81,1;81;81	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	78.9	1	SNP	p	S87R	1	.	.	259	261	CGT	754	756	CGT	95;96;96	C,A;G;T	81,1;81;81	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3318	78.9	1	SNP	p	S88P	0	.	.	262	264	TCC	757	759	TCC	95;95;95	T;C;C	80;79;80	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	748	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3071	72.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1769	1771	GGC	89;89;88	G;G;C	77;74;72	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1441	1443	GCC	101;101;100	G;C;C	81;76;80	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1444	1446	ATG	100;100;100	A;T;G,T,C	84;82;78,1,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1456	1458	ACC	106;106;106	A;C;C	89;87;91	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1456	1458	ACC	106;106;106	A;C;C	89;87;91	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1957	1959	ACC	95;95;96	A;C;C	82;80;83	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2011	2013	GCG	88;88;89	G;C;G	74;76;74	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2011	2013	GCG	88;88;89	G;C;G	74;76;74	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2134	2136	GGT	87;87;87	G;G;T	71;72;72	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2143	2145	AGC	88;88;88	A;G;C	72;71;71	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	702	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2687	78.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2161	2163	CCG	89;90;89	C,T;C;G	63,1;69;66	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	852	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3479	73.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1816	1818	CCG	83;83;82	C;C,T;G	64;63,1;67	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	424	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2190	57.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	807	807	C	67	C	60	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	78	porB1a	984	294	90.94	porB1a.l15.c4.ctg.1	1379	16.0	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1110	1112	AAT	8;8;8	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	78	porB1a	984	294	90.94	porB1a.l15.c4.ctg.1	1379	16.0	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1113	1115	AAT	8;7;7	A;A;T	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	78	porB1a	984	294	90.94	porB1a.l15.c4.ctg.1	1379	16.0	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1137	1139	GCA	6;6;6	G;C;A	5;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	78	porB1a	984	294	90.94	porB1a.l15.c4.ctg.1	1379	16.0	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1160	1162	GTA	6;6;6	G;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	78	porB1a	984	294	90.94	porB1a.l15.c4.ctg.1	1379	16.0	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1169	1169	A	5	A	4	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	434	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2014	63.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1169	1171	AGA	82;81;82	A;G;A	77;76;74	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	434	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2014	63.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1190	1192	GGT	83;83;83	G;G;T	75;76;76	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	434	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2014	63.6	1	SNP	p	G120K	1	.	.	358	360	AAG	899	901	AAG	79;79;79	A,C;A;G	66,1;67;65	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	434	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2014	63.6	1	SNP	p	N121D	0	.	.	361	363	AAC	902	904	AAC	79;78;78	A;A;C	65;67;65	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	434	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	2014	63.6	1	SNP	p	A121N	1	.	.	361	363	AAC	902	904	AAC	79;78;78	A;A;C	65;67;65	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1478	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5372	82.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	212	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1358	46.7	1	SNP	p	V57M	1	.	.	169	171	ATG	699	701	ATG	82;82;81	A;T;G,T	67;65;63,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
